What does this research mean for the field?

Sarcopenia is a highly prevalent, multifactorial complication of inflammatory bowel disease that is consistently associated with adverse clinical outcomes and requires standardized detection and integrated care frameworks. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

What question did this study set out to answer?

To synthesize evidence on the prevalence, underlying mechanisms, detection modalities, and clinical consequences of sarcopenia in adults with inflammatory bowel disease.

September 2, 2026LifeOpen Access

Sarcopenia in Inflammatory Bowel Disease: Prevalence, Mechanisms, Detection, Adverse Clinical Impact and Targetable Care Gaps—A Narrative Review Supported by a Structured Literature Search

View Full Paper

Ask AI

Bookmark

Authors

AVAlexandra-Ioana Vasilachi-Lulache PFPetruța Violeta Filip CCCosmin Alexandru Ciora

Discussion

Member takes

Overview

Narrative review reveals sarcopenia affects up to 50% of active IBD patients, indicating a critical need for integrated muscular assessment.

Key Points

To synthesize evidence on the prevalence, underlying mechanisms, detection modalities, and clinical consequences of sarcopenia in adults with inflammatory bowel disease.
Conducted a narrative review supported by a structured search across PubMed/MEDLINE and citation tracking for human studies published between January 1, 2010, and July 5, 2026.
Screened 133 unique records and assessed 66 full-text articles to include 54 eligible sources.
Synthesized data from 39 empirical studies, 5 systematic reviews or meta-analyses, 6 consensus documents, and 4 mechanistic reviews.
Sarcopenia prevalence varied based on diagnostic criteria, ranging from roughly 10% in stable outpatients assessed functionally to over 40% to 50% in active-disease or computed tomography-evaluated cohorts.
Pathophysiological drivers identified include chronic inflammation, malnutrition, dysbiosis, corticosteroid therapy, physical inactivity, and impaired anabolic signaling.
Sarcopenia correlated consistently with increased rates of hospitalization, abscess formation, postoperative complications, treatment failure, and physical disability.

Cite This Study

Vasilachi-Lulache et al. (2026) studied this question.

synapsesocial.com/papers/6a97e2c5c562ede874ec71ed https://doi.org/10.3390/life16091451

View Full Paper

Ask AI

Bookmark

September 2, 2026LifeOpen Access

Sarcopenia in Inflammatory Bowel Disease: Prevalence, Mechanisms, Detection, Adverse Clinical Impact and Targetable Care Gaps—A Narrative Review Supported by a Structured Literature Search

View Full Paper

Ask AI

Bookmark

Authors

AVAlexandra-Ioana Vasilachi-Lulache PFPetruța Violeta Filip CCCosmin Alexandru Ciora

Discussion

Member takes

Overview

Narrative review reveals sarcopenia affects up to 50% of active IBD patients, indicating a critical need for integrated muscular assessment.

Key Points

To synthesize evidence on the prevalence, underlying mechanisms, detection modalities, and clinical consequences of sarcopenia in adults with inflammatory bowel disease.
Conducted a narrative review supported by a structured search across PubMed/MEDLINE and citation tracking for human studies published between January 1, 2010, and July 5, 2026.
Screened 133 unique records and assessed 66 full-text articles to include 54 eligible sources.
Synthesized data from 39 empirical studies, 5 systematic reviews or meta-analyses, 6 consensus documents, and 4 mechanistic reviews.
Sarcopenia prevalence varied based on diagnostic criteria, ranging from roughly 10% in stable outpatients assessed functionally to over 40% to 50% in active-disease or computed tomography-evaluated cohorts.
Pathophysiological drivers identified include chronic inflammation, malnutrition, dysbiosis, corticosteroid therapy, physical inactivity, and impaired anabolic signaling.
Sarcopenia correlated consistently with increased rates of hospitalization, abscess formation, postoperative complications, treatment failure, and physical disability.

Cite This Study

Vasilachi-Lulache et al. (2026) studied this question.

synapsesocial.com/papers/6a97e2c5c562ede874ec71ed https://doi.org/10.3390/life16091451

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark